Showing results (41-50 of 94) with videos related to
Sort By:
Pageof 10
Diabetologia|February 24, 2006
A developmental nephron deficit in rats is associated with increased susceptibility to a secondary renal injury due to advanced glycation end-productsM A Zimanyi, K M Denton, J M Forbes, et al.Annals of Internal Medicine|December 7, 2005
Treatment of lateral epicondylitis with botulinum toxin: a randomized, double-blind, placebo-controlled trialShiu Man Wong, Andrew C F Hui, Po-Yee Tong, et al.Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|February 5, 2008
Fetal biometry in ethnic Chinese: biparietal diameter, head circumference, abdominal circumference and femur lengthT N Leung, M W Pang, S S Daljit, et al.Clinical Radiology|July 1, 1990
Magnetic resonance imaging in the clinical diagnosis of late temporal lobe necrosis following radiotherapy for nasopharyngeal carcinomaA W Lee, L O Cheng, S H Ng, et al.Cancer|August 1, 1995
Primary lymphoepithelioma-like carcinoma of the lung. A clinicopathologic study of 11 casesJ K Chan, P K Hui, W Y Tsang, et al.Human Pathology|August 1, 1994
In situ localization of Epstein-Barr virus encoded RNA in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphomasW Y Tsang, J K Chan, T T Yip, et al.Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1994
A randomized prospective study of the cost-effectiveness of the conventional spike, O-set, and UVXD techniques in continuous ambulatory peritoneal dialysisI K Cheng, C Y Chan, S W Cheng, et al.ANZ Journal of Surgery|March 22, 2002
Management of acute superior mesenteric artery occlusionMichael S Barakate, Ian Cappe, Austin Curtin, et al.Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|May 7, 2016
Effect of non-invasive prenatal testing as a contingent approach on the indications for invasive prenatal diagnosis and prenatal detection rate of Down's syndromeK O Kou, C F Poon, S L Kwok, et al.Bioorganic & Medicinal Chemistry Letters|October 16, 2004
3-[3-Fluoro-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)phenyl]-4-methylpyridine: a highly potent and orally bioavailable metabotropic glutamate subtype 5 (mGlu5) receptor antagonistSteve F Poon, Brian W Eastman, Deborah F Chapman, et al.Pageof 10